HGHugh Malcolm Douglas Gurling

Hugh Malcolm Douglas Gurling

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Hugh Malcolm Douglas Gurling has a total of 260 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Genome-wide association study of bipolar disorder in Canadian and UK populations corroborates disease loci including SYNE1 and CSMD1

    by Wei Xu, Sarah Cohen-Woods, Qian Chen, Abdul Noor, Jo Knight, Georgina Hosang, Sagar V Parikh, Vincenzo De Luca, Federica Tozzi, Pierandrea Muglia, et al.

    Background: Recently, genome-wide association studies (GWAS) for cases versus controls using single nucleotide polymorphism microarray data have shown promising findings for complex neuropsychiatric disorders, including bipolar disorder (BD).Methods: Here we describe a comprehensive genome-wide study of bipolar disorder (BD), cross-referencing analysis from a family-based study of 229 small families with association analysis from over 950 cases and 950 ethnicity-matched controls from the UK and Canada. Further, loci identified in these analyses were supported by pathways identified through pathway analysis on the samples.Results: Although no genome-wide significant markers were identified, the combined GWAS findings have pointed to several genes of interest that support GWAS findings for BD from other groups or consortia, such as atSYNE1on 6q25,PPP2R2Con 4p16.1,ZNF659on 3p24.3,CNTNAP5(2q14.3), andCDH13(16q23.3). This apparent corroboration across multiple sites gives much confidence to the likelihood of genetic involvement in BD at these loci. In particular, our two-stage strategy found association in both our combined case/control analysis and the family-based analysis on 1q21.2 (closest gene: sphingosine-1-phosphate receptor 1 gene,S1PR1) and on 1q24.1 near the geneTMCO1, and atCSMD1on 8p23.2, supporting several previous GWAS reports for BD and for schizophrenia. Pathway analysis suggests association of pathways involved in calcium signalling, neuropathic pain signalling, CREB signalling in neurons, glutamate receptor signalling and axonal guidance signalling.Conclusions: The findings presented here show support for a number of genes previously implicated genes in the etiology of BD, includingCSMD1andSYNE1, as well as evidence for previously unreported genes such as the brain-expressed genesADCY2,NCALD,WDR60,SCN7AandSPAG16.


  • Open Access

    Genetic Association, Mutation Screening, and Functional Analysis of a Kozak Sequence Variant in the Metabotropic Glutamate Receptor 3 Gene in Bipolar Disorder

    by Radhika Kandaswamy, Andrew McQuillin, Sally I. Sharp, Alessia Fiorentino, Adebayo Anjorin, Robert A. Blizard, David Curtis, Hugh M. D. Gurling

    The glutamate receptor 3 gene (GRM3; OMIM 601115) encodes the metabotropic glutamate receptor 3 (mGlur3) protein, which is a group II metabotropic glutamate neurotransmitter receptor that is similar to mGluR2. Metabotropic glutamate receptor 3 is a G protein–coupled receptor that acts by inhibition of adenylate cyclase and reducing cyclic adenosine monophosphate production.1 Group II mGluRs are involved in learning, memory, anxiety, and the perception of pain. Metabotropic glutamate receptor 3 is found on presynaptic and postsynaptic neurons in synapses of the hippocampus, cerebellum, and cerebral cortex, as well as other parts of the brain and in peripheral tissues. The mGluR3 receptors modulate glutamate concentrations by sensing excess synaptic glutamate release and providing a negative feedback mechanism that downregulates glutamate transmitter release. Activation of postsynaptic mGluR2/3 receptors can reduce neuronal excitability and plasticity through intracellular mechanisms, such as modulation of ion channels and induction of long-term synaptic depression.2 Studies3 also have suggested that mGluR2/3 receptors may function as heteroreceptors controlling the release of γ-aminobutyric acid and other neurotransmitters.


  • Principles of Psychiatric Genetics

    by Jr John I. Nurnberger, Wade H. Berrettini, Maricela Alarcón, Laura A. Baker, Trygve Bakken, Serena Bezdjian, Andrew W. Bergen, Laura J. Bierut, Andrew C. Chen, C. Robert Cloninger, et al.

    Disorders of behavior represent some of the most common and disabling diseases affecting humankind; however, despite their worldwide distribution, genetic influences on these illnesses are often overlooked by families and mental health professionals. Psychiatric genetics is a rapidly advancing field, elucidating the varied roles of specific genes and their interactions in brain development and dysregulation. Principles of Psychiatric Genetics includes 22 disorder-based chapters covering, amongst other conditions, schizophrenia, mood disorders, anxiety disorders, Alzheimer's disease, learning and developmental disorders, eating disorders and personality disorders. Supporting chapters focus on issues of genetic epidemiology, molecular and statistical methods, pharmacogenetics, epigenetics, gene expression studies, online genetic databases and ethical issues. Written by an international team of contributors, and fully updated with the latest results from genome-wide association studies, this comprehensive text is an indispensable reference for psychiatrists, neurologists, psychologists and anyone involved in psychiatric genetic studies.


  • Sequencing of the ANKYRIN 3 gene (ANK3) encoding ankyrin G in bipolar disorder reveals a non‐conservative amino acid change in a short isoform of ankyrin G

    by Alexandra Dedman, Andrew McQuillin, Radhika Kandaswamy, Sally Sharp, Adebayo Anjorin, Hugh Gurling

    Significant association between polymorphisms at the ANK3 gene with bipolar disorder has previously been reported and confirmed in several samples. Here we report on association between ANK3 and bipolar disorder in a new sample of 593 patients and 642 controls (UCL2) as well as the results of sequencing of the exons and flanking regions of ANK3 from bipolar patients. Single nucleotide polymorphisms (SNPs) associated with bipolar disorder in our original GWA study (UCL1) were genotyped and tested for association in the new sample. Novel SNPs found by sequencing were genotyped in both samples to test for association with bipolar disorder. None of the SNPs previously associated with bipolar disorder were associated in the UCL2 sample. One of the four SNPs associated in the UCL1 sample, rs1938526, was still significantly associated with bipolar disorder when the UCL1 and UCL2 samples were combined (P = 0.0095). The results demonstrate the impact of heterogeneity on replication of allelic associations even within well‐defined ancestral populations. DNA sequencing revealed a novel low frequency (0.007) ANK3 SNP (ss469104599) which causes a non‐conservative amino acid change at position 794 in the shorter isoforms of the ankyrin G protein. Protein‐function analysis software predicted the amino acid change to be “probably damaging” and it could therefore be detrimental to the function of this isoform. Given that there was only a modest increase in the allele frequency of ss469104599 in cases compared to controls further association studies are needed in additional samples to establish a possible etiological role for this amino acid change.


  • Confirmation of prior evidence of genetic susceptibility to alcoholism in a genome-wide association study of comorbid alcoholism and bipolar disorder

    by Gregory John Lydall, Nicholas J. Bass, Andrew McQuillin, Jacob Lawrence, Adebayo Anjorin, Radhika Kandaswamy, Ana Pereira, Irene Guerrini, David Curtis, Anna E. Vine, et al.

    Objectives Alcoholism and affective disorders are both strongly comorbid and heritable. We have investigated the genetic comorbidity between bipolar affective disorder and alcoholism. Methods A genome-wide allelic association study of 506 patients from the University College London bipolar disorder case–control sample and 510 ancestrally matched supernormal controls. One hundred forty-three of the bipolar patients fulfilled the Research Diagnostic Criteria diagnosis of alcoholism. A total of 372 193 single nucleotide polymorphisms (SNPs) were genotyped. Genes previously shown to be associated with alcoholism and addiction phenotypes were then tested for association in the bipolar alcoholic sample using gene-wise permutation tests of all SNPs genotyped within a 50-kb region flanking each gene. Results Several central nervous system genes showed significant (P<0.05) gene-wise evidence of association with bipolar alcoholism. The genes implicated, which replicated genes previously shown to be associated with alcoholism were: cadherin 11, collagen type 11 α2, neuromedin U receptor 2, exportin7, and semaphorin-associated protein 5A. The SNPs most strongly implicated in bipolar alcoholism, but, which did not meet conventional genome-wide significance criteria were the insulin-like growth factor-binding protein 7, carboxypeptidase O, cerebellin 2, and the cadherin 12 genes. Conclusion We have confirmed the role of some genes previously shown to be associated with alcoholism in the comorbid bipolar alcoholism subgroup. In this subgroup, bipolar disorder may lower the threshold for the phenotypic expression of these alcoholism susceptibility genes. We also show that some genes may independently increase susceptibility to affective disorder and alcoholism.


  • Quantitative and Molecular Genetics of ADHD

    by Philip Asherson, Hugh Gurling

    ADHD is a common and highly heritable disorder. Family, twin, and adoption studies confirm a strong genetic influence in risk for ADHD and there has been a great deal of interest in identifying the genetic factors involved. Quantitative genetic studies find that genetic risk for ADHD is continuously distributed throughout the population, that there are both shared and unique genetic influences on inattention and hyperactivity-impulsivity, and that ADHD shares genetic risk factors with commonly co-occurring clinical syndromes and traits. ADHD is found at all ages and the underlying genetic architecture is similar across the lifespan. In terms of specific genetic findings, there is consistent evidence of monoamine neurotransmitter involvement with the best evidence coming from genetic markers in or near the dopamine D4 and D5 receptor genes. Recent genome-wide association studies have identified new association findings, including genes involved in cell division, cell adhesion, neuronal migration, and neuronal plasticity. However, as yet, none of these pass genome-wide levels of significance. Finally, recent data confirm an important role for rare copy number variants, including those that are found in schizophrenia and autism. Future work should use genetic association data to determine the nature of the cognitive, neuronal and cellular processes that mediate genetic risks on behaviour, and identify environmental factors that interact with genetic risks for ADHD.


  • Genetic association study of GABRA2 single nucleotide polymorphisms and electroencephalography in alcohol dependence

    by G.J. Lydall, J. Saini, K. Ruparelia, S. Montagnese, A. McQuillin, I. Guerrini, H. Rao, G. Reynolds, D. Ball, I. Smith, et al.


  • Genetic association and sequencing of the insulin-like growth factor 1 gene in bipolar affective disorder

    by Ana C. Parente Pereira, Andrew McQuillin, Vinay Puri, Adebayo Anjorin, Nicholas Bass, Radhika Kandaswamy, Jacob Lawrence, David Curtis, Pamela Sklar, Shaun M. Purcell, et al.

    Insulin‐like growth factor 1 (IGF1) has been shown to have an important role in brain development and function. Studies of IGF1 administration in rodents have shown that it has an anxiolytic and antidepressant effect. A genome‐wide association study (GWAS) of the first University College London (UCL) cohort of 506 bipolar affective disorder subjects and 510 controls was carried out. The exons and flanking regions of IGF1 were resequenced, any new polymorphisms found were genotyped in an enlarged UCL sample of 937 cases and 941 controls. GWAS data gave good evidence of allelic and haplotypic association between multiple IGF1 SNP's and bipolar disorder (BD). New polymorphisms were found by resequencing IGF1 region. Data from GWAS and the new markers showed that twelve out of 43 SNPs showed association with BD with the four most significant SNPs having values of 3.7 × 10−5, 8.4 × 10−4, 2.6 × 10−4, and 2.5 × 10−4. A 5′ promoter microsatellite polymorphism previously correlated with plasma lipoprotein concentration was also associated with BD (P = 0.013). Haplotypic association confirmed association with BD with significance values similar to the single marker SNP values. The marker rs12426318 has also been found to be associated with BD in a second sample. A test of gene wide significance with permutation testing for all markers genotyped at IGF1 was also significant. These data implicate IGF1 as a candidate gene to cause genetic susceptibility to BD.


  • Meta-analysis of genome-wide association data of bipolar disorder and major depressive disorder

    by Y Liu, D H Blackwood, S Caesar, E J C de Geus, A Farmer, M A R Ferreira, I N Ferrier, C Fraser, K Gordon-Smith, E K Green, et al.